Pulmonary Drug Delivery Market Report: Trends, Forecast and Competitive Analysis to 2030

Pulmonary Drug Delivery Trends and Forecast

The future of the global pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets. The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030 with a CAGR of 2.5% from 2024 to 2030. The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.

A more than 150-page report is developed to help in your business decisions.

Pulmonary Drug Delivery by Segment

The study includes a forecast for the global pulmonary drug delivery by application, end use, distribution channel, and region.

Pulmonary Drug Delivery Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Asthma
• Chronic Obstructive Pulmonary Disease
• Allergic Rhinitis
• Cystic Fibrosis
• Others

Pulmonary Drug Delivery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Home Care

Pulmonary Drug Delivery Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

Pulmonary Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pulmonary Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pulmonary drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pulmonary drug delivery companies profiled in this report include-

• Glaxosmithkline
• 3M Company
• Koninklijke Philips
• Astrazeneca
• Boehringer Ingelheim

Pulmonary Drug Delivery Market Insights

Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.

Within this market, hospitals & clinics will remain the larger segment due to growing number of hospital pharmacies across the globe.

North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.

Features of the Global Pulmonary Drug Delivery Market

Market Size Estimates: Pulmonary drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pulmonary drug delivery market size by application, end use, distribution channel, and region in terms of value ($B).

Regional Analysis: Pulmonary drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications, end uses, distribution channels, and regions for the pulmonary drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pulmonary drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pulmonary drug delivery market size?

Answer: The global pulmonary drug delivery market is expected to reach an estimated $68.1 billion by 2030.

Q.2 What is the growth forecast for pulmonary drug delivery market?

Answer: The global pulmonary drug delivery market is expected to grow with a CAGR of 2.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pulmonary drug delivery market?

Answer: The major drivers for this market are rising prevalence of respiratory diseases, growing awareness towards the benefits of pulmonary drug delivery, and increasing demand for home-based healthcare services.

Q4. What are the major segments for pulmonary drug delivery market?

Answer: The future of the pulmonary drug delivery market looks promising with opportunities in the hospitals & clinic and home care markets.

Q5. Who are the key pulmonary drug delivery market companies?

Answer: Some of the key pulmonary drug delivery companies are as follows:

• Glaxosmithkline
• 3M Company
• Koninklijke Philips
• Astrazeneca
• Boehringer Ingelheim

Q6. Which pulmonary drug delivery market segment will be the largest in future?

Answer: Lucintel forecasts that chronic obstructive pulmonary disease (COPD) will remain the largest segment over the forecast period due to increasing prevalence of respiratory diseases and favorable reimbursement policies towards the treatment of chronic obstructive pulmonary disease.

Q7. In pulmonary drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to advanced healthcare system, which provides patients with access to the latest pulmonary drug delivery devices and treatments.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pulmonary drug delivery market by application (asthma, chronic obstructive pulmonary disease, allergic rhinitis, cystic fibrosis, and others), end use (hospitals & clinics and home care), distribution channel (hospital pharmacies, retail pharmacies, and e-commerce), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?